Sun Pharmaceutical Industries Limited Announces 34th AGM and Final Dividend for FY 2025-26

Sun Pharmaceutical Industries Limited has announced its 34th Annual General Meeting (AGM) scheduled for Friday, July 31, 2026, at 4:00 p.m. IST via Video Conferencing. The company also set the record date for its final dividend for FY 2025-26 as Tuesday, July 07, 2026. Shareholders are advised to update their details to ensure timely receipt of the annual report and dividend, which is proposed at ₹5 per equity share.

34th Annual General Meeting Details

Sun Pharmaceutical Industries Limited will convene its 34th Annual General Meeting (AGM) on Friday, July 31, 2026. The meeting is scheduled to commence at 4:00 p.m. IST and will be conducted virtually through Video Conferencing (VC). Shareholders can expect the Notice for the AGM and the Annual Report for the financial year 2025-26 to be dispatched in due course, in compliance with all statutory requirements.

Shareholders are urged to ensure their latest contact information, including email addresses and physical addresses, are current with their respective Depository Participants (for dematerialized shares) or the Company’s Registrar and Transfer Agent (for physical shares). This is crucial for the timely delivery of the Annual Report, AGM Notice, and for the smooth credit of their dividend.

Record Date and Final Dividend for FY 2025-26

The company has fixed Tuesday, July 07, 2026, as the Record Date for determining the eligibility of shareholders for the final dividend for the financial year 2025-26. The proposed final dividend amounts to ₹5/- (Rupees Five only) per equity share. If this dividend receives approval from the shareholders at the AGM, the payment will be processed on or before Friday, August 07, 2026.

Submission of Documents for TDS on Dividend

Dividend payments are subject to applicable rates of tax deduction at source (TDS). Shareholders are encouraged to consult the TDS guidance and document submission process available on the company’s official website, www.sunpharma.com, or by using the provided QR code. Any necessary documents required for TDS purposes should be submitted no later than Tuesday, July 07, 2026, to ensure the correct TDS rate is applied.

Source: BSE

Previous Article

Rain Industries Limited Rain Carbon Inc. Releases CY2025 Sustainability Report

Next Article

Sumitomo Chemical India Ltd. Announces Audited Financial Results for FY 2025-26